Recommendations for the Use of Herpes Zoster Vaccines
Date: Thursday, May 10, 2018
Time: 2:00pm-3:00pm (Eastern Time)
Instructions for Obtaining Continuing Education (CE)
To receive continuing education (CE) for WC2922-051018 – (Webcast) Clinician Outreach and Communication Activity (COCA) Calls/Webinars – “Recommendations for the Use of Herpes Zoster Vaccines” please visit TCEO and follow these 9 Simple Steps by June 11, 2018.
To receive continuing education (CE) for WD2922-051018 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – “Recommendations for the Use of Herpes Zoster Vaccines” (Web on Demand), please visit TCEO and follow these 9 Simple Steps by June 12, 2020.
Herpes zoster, also known as shingles, is a common viral disease with about one million cases each year in the United States. In October 2017, the Food and Drug Administration (FDA) approved a 2-dose, recombinant zoster vaccine ([RZV], Shingrix), for the prevention of herpes zoster in adults aged ≥50 years. The Centers for Disease Control and Prevention (CDC) recommends Shingrix for use in immunocompetent adults age ≥50 years. During this COCA Call, clinicians will learn about CDC recommendations for herpes zoster vaccines and the clinical guidelines for the new vaccine.
At the conclusion of the session, the participant will be able to accomplish the following:
- List CDC’s recommendations on herpes zoster vaccines, in particular, new guidelines for Shingrix.
- Explain who should receive Shingrix and how to administer it.
- Describe the benefits and side effects of Shingrix.
Kathleen Dooling, MD, MPH
Division of Viral Diseases
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
- Webinar/Audio conference call on 5/10/2018: 2:00 – 3:00 PM ET
- Web-on-demand training after 3:00 PM ET on 5/10/2018
- Materials: PowerPoint slide set
“WC2922” for attendees who participate in the live call (must be completed by June 11, 2018)
“WD2922” for attendees who participate in the online presentation (must be completed by June 12, 2020)
- Physician Assistants
- Health Educators
- Other Clinicians
- Contact Information:email@example.com
- Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communications Branch
- Method of Participation:You may participate in the educational activity by viewing the program information above.
- Fees:COCA continuing education credits are free.
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 1.0 contact hour.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-18-148-L04-P and enduring 0387-0000-18-148-H04-P course category.
This activity has been designated as Knowledge-Based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.
AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this continuing education activity.
- Page last reviewed: April 20, 2018
- Page last updated: May 11, 2018
- Content source:
- Maintained By: